Get the Stockscreener App
7.48
1.91%
0.14
Pre-market:
7.71
0.23
+3.07%
Kamada Ltd stock is traded at $7.48, with a volume of 47,790.
It is up +1.91% in the last 24 hours and down -3.48% over the past month.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
See More
Previous Close:
$7.34
Open:
$7.38
24h Volume:
47,790
Relative Volume:
0.69
Market Cap:
$422.09M
Revenue:
$154.57M
Net Income/Loss:
$15.07M
P/E Ratio:
27.70
EPS:
0.27
Net Cash Flow:
$10.92M
1W Performance:
+9.20%
1M Performance:
-3.48%
6M Performance:
-7.54%
1Y Performance:
+39.81%
1-Day Range:
$7.37
$7.50
1-Week Range:
$6.81
$7.50
52-Week Range:
$5.17
$9.155
Kamada Ltd Stock (KMDA) Company Profile
Compare KMDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
7.48 | 422.09M | 154.57M | 15.07M | 10.92M | 0.27 |
|
ZTS
Zoetis Inc
|
149.77 | 66.04B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.63 | 45.57B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.58 | 42.50B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.60 | 18.84B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.39 | 13.59B | 2.99B | 1.21B | 1.13B | 25.06 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Initiated | The Benchmark Company | Buy |
| Jul-03-24 | Initiated | Stifel | Buy |
| Feb-02-18 | Initiated | Chardan Capital Markets | Buy |
Kamada Ltd Stock (KMDA) Latest News
Kamada: Q2 Earnings Snapshot - San Francisco Chronicle
Kamada Ltd. Reports Strong Financial Results and FDA Approval in August 2025 - TipRanks
Kamada Reports Strong Second Quarter and First Half 2025 - GlobeNewswire
How sentiment analysis helps forecast Kamada Ltd.July 2025 Review & Technical Analysis for Trade Confirmation - Newser
How hedge fund analytics apply to Kamada Ltd. stock2025 Geopolitical Influence & Safe Investment Capital Preservation Plans - Newser
Strategies to average down on Kamada Ltd.2025 Short Interest & Long-Term Safe Investment Plans - Newser
Will Kamada Ltd. rebound enough to break even2025 Valuation Update & Fast Moving Stock Trade Plans - Newser
Can Kamada Ltd. deliver alphaMulti-Year Breakout Candidates - metrotimes.co.kr
What makes Kamada Ltd. stock price move sharplyWeekly Stock Market Strategy Summary - Newser
Kamada Ltd. shares fall 2.45% after-hours as Houston Center begins sales of Normal Source Plasma. - AInvest
Kamada Says Houston Center Cleared to Begin Sales of Normal Source Plasma - MarketScreener
Kamada’s Houston Plasma Center Gains FDA Approval - TipRanks
FDA approves Kamada’s Houston plasma collection center - Investing.com
Kamada Announces FDA Approval of its Plasma Collection Center in Houston, Texas - GlobeNewswire
Kamada Secures FDA Approval for $10M Revenue Plasma Center, Set to Be Largest Specialty Collection Site - Stock Titan
Intrinsic Value of Kamada Ltd. Stock: Is It Undervalued or OvervaluedFree Daily Volume Spike Trading Signals - Newser
Kamada (KMDA) Expected to Announce Earnings on Wednesday - Defense World
Screener Results Flag Kamada Ltd. as OversoldWealth Building Stock Market Ideas Based on Momentum - metal.it
What recovery options are there for Kamada Ltd.Free Pattern Detection for Entry Confirmation - Newser
Is Kamada Ltd. a top pick in the sectorCompounding Growth Ideas - kangso.co.kr
Exploring Analyst Estimates for Kamada (KMDA) Q2 Earnings, Beyond Revenue and EPS - Yahoo Finance
Full technical analysis of Kamada Ltd. stockProfitable Trading Blueprint with Entry Zones - Newser
Kamada Announces Q2 and H1 2025 Financial Results on August 13, 2025. - AInvest
How to recover losses in Kamada Ltd. stockPrice Action Trading with Volume Confirmation - Newser
Kamada to Announce Q2 and H1 2025 Financial Results on August 13, 2025 - AInvest
Kamada to Announce Second Quarter and First Half Ended June 30, 2025 Financial Results on August 13, 2025 - 富途牛牛
Is Kamada Ltd. still worth holding after the dipMomentum Prediction Based on AI Backtesting - Newser
Kamada Q2 Earnings: Rare Disease Biotech Giant Reveals Latest Financial Results Next Week - Stock Titan
Alpha-1 Antitrypsin Deficiency Pipeline Assessment Report - openPR.com
What is Kamada Ltd. company’s growth strategyAccelerated earnings growth - Jammu Links News
What are analysts’ price targets for Kamada Ltd. in the next 12 monthsTremendous return on equity - Jammu Links News
What is the dividend policy of Kamada Ltd. stockBuild a diversified portfolio for steady growth - Jammu Links News
What are the latest earnings results for Kamada Ltd.Free Trading Psychology Coaching - Jammu Links News
What markets is Kamada Ltd. expanding into Is TZOO stock a good long term investment optionExceptional ROI - Jammu Links News
What institutional investors are buying Kamada Ltd. stockGet daily expert analysis for smarter investing - Jammu Links News
Does Kamada Ltd. stock perform well during market downturnsUnlock powerful stock screening for profits - Jammu Links News
Is Kamada Ltd. a growth stock or a value stockHigh-octane gains - Jammu Links News
Why is Kamada Ltd. stock attracting strong analyst attentionMaximize profits with strategic stock selection - Jammu Links News
What markets is AVAH expanding into Is Kamada Ltd. stock a good long term investment optionBuild a diversified portfolio for sustainable growth - Jammu Links News
How does Kamada Ltd. compare to its industry peersFree Stock Market Trend Analysis - Jammu Links News
Is Kamada Ltd. a good long term investmentBuild a strong portfolio for long-term success - Jammu Links News
Kamada Ltd. stock daily chart insightsSwing Trade Signal and Price Prediction - Newser
Kamada Ltd Stock (KMDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):